Purchase Order 75N98025P01559
Award Date
6/20/25
Potential Completion Date
1/31/26
Potential Value
$122K
Funding Federal Agency
National Institute on Deafness and Other Communincation Disorders
Contracting Federal Agency
Office of Logisitics and Acquisition Operations
Awardee
Pine Pharmaceuticals LLC
Ultimate Awardee
Not listed
NAICS Category
339112 - Surgical and Medical Instrument Manufacturing
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Tonawanda, NY 14150, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $22,303.20 firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services (HHS), to Pine Pharmaceuticals LLC, a small business based in Tonawanda, New York. The contract is for the acquisition of an intravenous stable isotope, which is likely a specialized pharmaceutical product used in metabolic and clinical research studies conducted by NIDDK and other HHS...
This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the U.S. Department of Health and Human Services, to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The $12,580.80 contract is for the acquisition of intravenous stable isotopes, which are specialized pharmaceutical compounds used in metabolic and clinical research studies. Pine Pharmaceuticals is an...
This is a $15,000 firm fixed-price delivery order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services (HHS), to Pine Pharmaceuticals LLC, a for-profit limited liability company. The contract is for the provision of non-severable task order 1 for metabolic isotopes to support research studies conducted by various HHS agencies. Pine Pharmaceuticals is an FDA-registered 503B...
This $116,700.00 firm fixed price purchase order was awarded to Pine Pharmaceuticals LLC, a for-profit limited liability company, by the Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations. The contract has a completion date of August 17, 2023 and does not have a set-aside designation. Based on the information provided, Pine Pharmaceuticals is an FDA-registered 503B outsourcing facility that has previously provided pharmaceutical...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Pine Pharmaceuticals, LLC, a for-profit limited liability company. The contract has a potential value of $135,442.20 and a completion date of September 25, 2019. There is no set-aside designation mentioned. Based on the information provided, Pine Pharmaceuticals has a history...
This is a firm-fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), an agency within the U.S. Department of Health and Human Services (HHS), to Pine Pharmaceuticals LLC for the procurement of intravenous stable isotope (6,6 D2-Glucose) for metabolic research. The $138,712.14 contract has an ultimate completion date of November 2, 2024 and was awarded on a sole-source basis without a small business set-aside. Pine Pharmaceuticals is an...
This is a $27,384.76 firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The contract is for the provision of 3 batches/shipments of 60 units each of the intravenous stable isotope D5 glycerol, which is required for metabolic research studies conducted...
The National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases has awarded a $15,400 firm fixed price purchase order to Pine Pharmaceuticals LLC. The contract is for the delivery of 6,6 D2Glucose intravenous stable isotopes to support metabolic research studies being conducted by NIDDK in Tonawanda, New York. Pine Pharmaceuticals is an FDA-registered 503B outsourcing facility specializing in high-quality pharmaceutical compounds and repackaged products, with...
This is a firm-fixed price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), which is part of the U.S. Department of Health and Human Services (HHS), to Pine Pharmaceuticals LLC, a for-profit limited liability company. The contract is for the procurement of 6,6 D2-glucose 72.9 mg/ml (30 ml) vials, which are likely being used to support metabolic research studies conducted by NICHD. The contract has a ceiling value of $12,371.12 and a period of...
This is a $125,812.80 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Pine Pharmaceuticals LLC, a for-profit limited liability company. The contract is for the acquisition of intravenous stable isotopes, specifically 6,6 deuterated glucose and d5 glycerol, to support metabolic research conducted by NIDDK. The contract was awarded on a non-competitive, sole-source basis, as Pine Pharmaceuticals is the only approved...